Phase 1b Study to Evaluate QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT)
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Zuretinol acetate (Primary)
- Indications Leber congenital amaurosis; Retinitis pigmentosa
- Focus Therapeutic Use
- Sponsors QLT
- 27 Nov 2013 New trial record